scholarly journals Preoperative Contrast-Enhanced Ultrasound (CEUS) Combined with 125I Seeds Localization in Sentinel Lymph Node Biopsy for Breast Cancer

2021 ◽  
Vol Volume 13 ◽  
pp. 1853-1860
Author(s):  
Pengpeng Zhou ◽  
Weizhen Zheng ◽  
Yanbing Liu ◽  
Yongsheng Wang
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Lymph Node Biopsy ◽  
Contrast Enhanced Ultrasound ◽  
125I Seeds ◽  
Node Biopsy ◽  
Contrast Enhanced

scholarly journals The value of contrast‐enhanced ultrasound in determining the location of sentinel lymph nodes in breast cancer

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Jun Luo ◽  
Liting Feng ◽  
Qing Zhou ◽  
Qin Chen ◽  
Jinping Liu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Lymph Nodes ◽  
Lymph Node Biopsy ◽  
Contrast Enhanced Ultrasound ◽  
Breast Cancer Patients ◽  
Identification Rate ◽  
Node Biopsy ◽  
Contrast Enhanced

Abstract Background This study aimed to explore the sentinel lymph node (SLN) identification rate in breast cancer by subcutaneous and intradermal injection of ultrasound contrast agent in the mammary areola region, compared to the results achieved with methylene blue (MB). Methods A total of 390 breast cancer patients with planned sentinel lymph node biopsy from our breast surgery department from July 2017 to February 2019 were enrolled. All patients were subjected to preoperative contrast-enhanced ultrasound (CEUS), that involved an intracutaneous injection of 1 mL ultrasonic contrast agent (UCA) at 3 and 6 o ‘clock, as well as a subcutaneous injection of 1 mL UCA at 9 and 12 o’clock. The enhanced lymph nodes along the enhanced lymphatic vessels from the mammary areola were traced. The number of enhanced lymph nodes were recorded, and an ultrasound-guided injection of 1:10 diluted carbon nanoparticles were used to mark all first site enhanced lymph nodes (i.e., SLNs). An intraoperative dye method (MB) was used to track the SLNs and the results were compared with the CEUS findings. Results Among the 390 cases of breast cancer, enhanced SLNs were observed in 373 patients after an injection of UCA with an identification rate of 95.64 % (373/390), compared to the identification rate of 92.05 % (359/390) using the intraoperative MB. The difference between the two methods was statistically significant (P = 0.016). And among the 390 patients, a total of 808 enhanced lymph nodes were traced by preoperative CEUS, with a median of 2 (1,3). A total of 971 blue-stained lymph nodes were traced using the intraoperative MB, with a median of 2 (2,3), indicating a statistically significant difference (p < 0.001). Conclusions Intradermal and subcutaneous injections of UCA in the mammary areola region may have clinical application value for the identification and localization of SLNs in breast cancer patients. The identification rate is higher than that of blue dye method, which can be used as a new tracer of sentinel lymph node biopsy and complement other staining methods to improve the success rate.

Contrast-enhanced ultrasound-guided Sentinel lymph node biopsy of the ocular conjunctiva

2014 ◽  
Vol 124 (11) ◽  
pp. 2531-2536 ◽  
Author(s):  
Mindy R. Rabinowitz ◽  
Daniel A. Merton ◽  
Ji-Bin Liu ◽  
Shivam Saxena ◽  
John Pluta ◽  
...  
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Lymph Node Biopsy ◽  
Contrast Enhanced Ultrasound ◽  
Ultrasound Guided ◽  
Node Biopsy ◽  
Contrast Enhanced

The feasibility of sentinel lymph node biopsy in breast cancer patients after primary systemic therapy

2008 ◽  
Vol 68 (S 01) ◽  
Author(s):  
R Reitsamer ◽  
C Menzel ◽  
S Glück ◽  
E Schlederer ◽  
C Wilhelm ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Cancer Patients ◽  
Systemic Therapy ◽  
Lymph Node Biopsy ◽  
Breast Cancer Patients ◽  
Primary Systemic Therapy ◽  
Node Biopsy

Prospective Randomized Trial of Use of In-House Prepared Low-Cost Radiopharmaceutical Versus Commercial Radiopharmaceutical for Sentinel Lymph Node Biopsy in Patients with Early Stage Invasive Breast Cancer

2018 ◽  
Vol 42 (5) ◽  
pp. 1391-1395
Author(s):  
Gaurav Agarwal ◽  
Sendhil Rajan ◽  
Sabaretnam Mayilvaganan ◽  
Anjali Mishra ◽  
Narendra Krishnani ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Randomized Trial ◽  
Invasive Breast Cancer ◽  
Early Stage ◽  
Low Cost ◽  
Lymph Node Biopsy ◽  
Node Biopsy

Current status of sentinel lymph-node biopsy in patients with breast cancer

2010 ◽  
Vol 38 (3) ◽  
pp. 562-575 ◽  
Author(s):  
Gang Cheng ◽  
Stephanie Kurita ◽  
Drew A. Torigian ◽  
Abass Alavi
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Lymph Node Biopsy ◽  
Current Status ◽  
Node Biopsy
Sign in / Sign up

Export Citation Format

Share Document